This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-outlook: Archive
Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates
by Zacks Equity Research
Travere (TVTX) delivered earnings and revenue surprises of +16.73% and -8.97%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
TVTXPositive Net Change RXRXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LegalZoom (LZ) Q4 Earnings Lag Estimates
by Zacks Equity Research
LegalZoom (LZ) delivered earnings and revenue surprises of -7.61% and +3.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
LZNegative Net Change GICPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Ardelyx (ARDX) Reports Break-Even Earnings for Q4
by Zacks Equity Research
Ardelyx (ARDX) delivered earnings and revenue surprises of -100.00% and +6.51%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ARDXNegative Net Change AKBANo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Should You Buy D-Wave Stock Ahead of Q4 Earnings Release?
by Urmimala Biswas
QBTS' Q4 2025 results are expected to reflect strong bookings and tech progress, but lofty valuation and margin pressure may cap upside.
IONQNegative Net Change RGTINegative Net Change QBTSNegative Net Change
consensus-outlook earnings-estimates-revisions earnings-outlook earnings-preview earnings-streak earnings-surprise tech-stocks
Trimble (TRMB) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Trimble (TRMB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TRMBPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RCELPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Yara International ASA (YARIY) Rating Upgrade to Strong Buy
by Zacks Equity Research
Yara International ASA (YARIY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
YARIYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
RBC Bearings (RBC) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
RBC Bearings (RBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
RBCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Heineken (HEINY) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Heineken (HEINY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
HEINYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Bausch + Lomb (BLCO) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Bausch + Lomb (BLCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BLCOPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank